top of page


TRENOS SiGINT: CRISPR Supercharges Mycoprotein
A next-generation mycoprotein platform has emerged via CRISPR-engineered Fusarium venenatum, enabling 88% faster biomass production, 44% lower sugar input, and up to 60% lower emissions. This materially shifts cost curves, potentially enabling broader retail penetration and finally addressing alt-protein’s affordability ceiling. The consumer effect is simple: better texture, cheaper protein, and less “processing guilt” compared with traditional isolates.

Scott Mathias
3 days ago2 min read
bottom of page
